Previous Article | Next Article ![]()
Journal of Clinical Microbiology, November 2001, p. 4175-4177, Vol. 39, No. 11
Division of Infectious Diseases, SUNY
Downstate Medical Center, Brooklyn, New York 11203
Received 13 June 2001/Returned for modification 25 July
2001/Accepted 16 August 2001
Fifty-two isolates of Streptococcus pneumoniae
were characterized by pulsed-field gel electrophoresis (PFGE)
and automated ribotyping by using HindIII and
PvuII. HindIII ribotypes correlated well
with PFGE. PvuII produced fewer bands and was less
discriminatory. Automated ribotyping with HindIII is an
accurate method for genetic fingerprinting of S.
pneumoniae and can complement PFGE.
Penicillin-resistant
Streptococcus pneumoniae has become common in many areas of
the world and accounts for nearly 25% of isolates in the United States
(16). While there is considerable genetic diversity among
penicillin-resistant S. pneumoniae in Africa (7,
11), three particular clones During two citywide surveillances conducted in 1997 and 1999, all
unique patient isolates of S. pneumoniae were collected from
15 hospitals in Brooklyn, N.Y. Susceptibility testing was performed by
using either the broth microdilution method with 4% lysed horse blood
in cation-supplemented Mueller-Hinton broth (10) or by the
E-test method with Mueller-Hinton agar with 5% sheep blood. Serotypes
were determined commercially by using appropriate antisera (Statens
Serum Institute [Denmark]).
Chromosomal DNA from each isolate was prepared according to established
methods (12), with minor modifications. Briefly, 10 ml of
an early-stationary-phase culture was centrifuged and then washed and
resuspended with PIV buffer (10 mM Tris [pH 8.0], 1 M NaCl). The
concentration was adjusted to an optical density at 620 nm of 5.0 and
diluted 1:1 with low-melting-point agarose. The cells were placed in EC
lysis solution (6 mM Tris [pH 8.0], 1 M NaCl, 0.1 M EDTA [pH 8.0],
0.2% deoxycholate, 5% Sarkosyl) with RNase (50 µg/ml) and then
incubated with ES buffer (0.5 M EDTA [pH 9], 1% Sarkosyl) containing
proteinase K (1 mg/ml) at 50°C overnight. The disks were washed and
stored in TE buffer (10 mM Tris, 1 mM EDTA [pH 7.5]). The DNA was
restricted with SmaI overnight at 21°C. The DNA was then
separated by using contour clamp electrophoresis (CHEF III) for
20 h at 13°C at 6 V/cm and ramped pulse times with an
initial switch time of 1 s and a final switch time of
30 s. Isolates were compared to known epidemic clones based
on their PFGE patterns (1); isolates were considered related if they differed by Ribosomal DNA from each isolate was also studied by using the
Riboprinter Microbial Characterization System (Qualicon, Wilmington, Del.). Overnight cultures were treated with lysis buffer and placed into the automated Characterization System. Two restriction
enzymes were studied, HindIII and PvuII.
Digestion with PvuII was performed according to the
manufacturer's recommendations. Digestion with HindIII
(20,000 U/ml) was performed with an extended incubation (120 min at
37°C). In the automated system, restriction fragments are separated
by electrophoresis and then transferred to a nylon membrane. After
hybridization with a chemiluminescent DNA probe containing the rRNA
operon from Escherichia coli, the banding patterns were
imaged and stored in a computerized database. Isolates were immediately
compared to those in the database and were considered related if they
had similarity coefficients of A total of 144 isolates were collected during the surveys: 29 were
resistant (MIC
0095-1137/01/$04.00+0 DOI: 10.1128/JCM.39.11.4175-4177.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.
Comparison of Automated Ribotyping to Pulsed-Field Gel
Electrophoresis for Genetic Fingerprinting of
Streptococcus pneumoniae
![]()
ABSTRACT
Top
Abstract
Text
References
![]()
TEXT
Top
Abstract
Text
References
the Spanish-U.S. serotype 23F
(1, 2, 6, 8, 13, 17), the Spanish-French serotype 9/14
(1, 2, 6), and the Spanish serotype 6B (12, 15,
17)
have predominated in most epidemiological studies in
Europe, Asia, and the Americas. Several fingerprinting techniques have
been used, including pulsed-field gel electrophoresis (PFGE) (1,
2, 13, 15), multilocus enzyme electrophoresis (MLEE) (8,
12, 15), PCR-based genomic profiling (2, 6, 15), and ribotyping (7, 8, 13, 17). Comparatively few studies have compared these fingerprinting techniques; MLEE was similar to
ribotyping in two studies (7, 8). PFGE, BOX fingerprinting with repetitive sequences of S. pneumoniae as the DNA probe,
and restriction fragment end labeling provided the highest degree of
discrimination for fingerprinting S. pneumoniae in one
comparative study (5).
6 bands (14).
0.93. In this program, both band
position and intensity are used to determine the similarity coefficients.
2 µg/ml), 24 were intermediate
(MIC = 0.12 to 1 µg/ml), and 91 were susceptible to
penicillin. Fingerprinting was performed with 52 isolates, including 29 resistant, 6 intermediate, and 17 susceptible isolates. Penicillin
intermediate and susceptible isolates were selected to represent all of
the geographic neighborhoods in the city. A total of 21 PFGE types, 25 HindIII ribotypes, and 21 PvuII ribotypes
were identified. Eight isolates were identified by PFGE as belonging to
cluster A, which resembled the Spanish-U.S. 23F clone (Table
1). Six were resistant to penicillin, and
seven belonged to either the 23F or the 19F serotype. Six belonged
to one HindIII ribotype, and two had unique ribotypes
(Fig. 1). One of the unique
HindIII ribotypes was a non-23 valent vaccine serotype and susceptible to penicillin, suggesting it may have had a different genetic ancestry. Seven isolates belonged to a single PvuII
ribotype (Fig. 1).
TABLE 1.
Results of ribotyping after digestion with
HindIII versus PvuII of clones identified by
PFGE

View larger version (56K):
[in a new window]
FIG. 1.
Serotypes and fingerprint patterns of seven isolates of
cluster A. PFGE patterns of chromosomal DNA fragments digested with
SmaI (A) and ribotype profiles after digestion with
HindIII (B) or PvuII (C) are shown.
Nearly all isolates belonged to a single HindIII (H1) or
PvuII (P1) ribotype. NV, non-23 valent vaccine serotype.
Eleven isolates (cluster B) had a PFGE pattern resembling the
Spanish-French 9/14 clone (Table 1; Fig.
2); seven were resistant and two were
intermediate to penicillin. Ten belonged to serotypes 9V or 14, and one
was a nonvaccine serotype. Nine belonged to a single
HindIII ribotype, and the remaining two each had unique ribotypes (Fig. 2). Seven belonged to a single PvuII
ribotype, and the remaining four each belonged to unique ribotypes
(Fig. 2).
|
Two other PFGE clusters were identified (Table 1). Cluster C included eight isolates; all were resistant to penicillin, and seven were serotype 19F. Five isolates belonged to one HindIII ribotype, and three belonged to a second ribotype. Three of these isolates belonged to one PvuII ribotype, two belonged to a second ribotype, two belonged to a third ribotype, and the remaining isolate belonged to a unique ribotype. Four isolates belonged to cluster D; three were serotype 6B and penicillin resistant. All four isolates belonged to one HindIII ribotype, but all four belonged to different PvuII ribotypes.
PFGE revealed four clusters with two isolates apiece; one pair was penicillin resistant and serotype 6B. Isolates from three of the four clusters were paired together by HindIII. Similarly, three were paired by PvuII ribotypes, but considerable overlap with other PFGE clones occurred.
Unique PFGE patterns were found for the remaining 13 isolates (Table 1). All 13 possessed unique HindIII ribotypes. Only eight unique ribotypes were identified by PvuII; the remaining five isolates were grouped with previously found ribotypes (including clusters A and B ribotypes).
PFGE (1, 2, 12) and ribotyping (5, 7, 13, 17) have been frequently used to characterize the important international clones of resistant S. pneumoniae. Ribotyping with PvuII was less discriminatory in one study (5), but only one ribosomal probe (16S) was employed. PFGE and ribotyping with PvuII were comparable in identifying 18 Spanish-U.S. 23F strains among 22 isolates (13). Ribotyping with EcoRI correlated with MLEE and penicillin-binding gene fingerprinting in a small number of isolates (7). Automated ribotyping with EcoRI was used to analyze more than 200 isolates, but a comparison to other fingerprint methods was not done (17). Ribotyping with HindIII was comparable to MLEE in distinguishing 15 resistant Spanish-U.S. 23F isolates from a small number of other multidrug-resistant isolates (8). Seven resistant serotype 23F isolates were grouped together by ribotyping with HindIII, MLEE, and PFGE (9). Similar ribotype patterns were seen among a small number of serotype 6B isolates, but comparison to other fingerprint methods was not performed (4). With PFGE as the "gold standard," we found that ribotype profiles obtained with PvuII digestion were less discriminatory than those obtained with HindIII. Ribotype patterns obtained after digestion with HindIII were comparable to and can complement those obtained by PFGE.
Fingerprinting by PFGE can be laborious, and analysis can be difficult; genetic relationships may not be evident by PFGE if only a small number of isolates are tested. Guidelines for PFGE interpretation may not be applicable to epidemiological studies involving diverse geographic areas (3). Automated ribotyping is technically undemanding, requiring only ca. 30 min for preparation. Fingerprints from as many as 32 isolates can be obtained within 24 h, providing timely results for epidemiological investigations. With the standardization of banding patterns, interinstitutional comparison of ribotype profiles can be easily and reliably performed, allowing for comparison of isolates from different geographic areas. The major disadvantage of automated ribotyping is the cost, approximately $45 per isolate.
| |
ACKNOWLEDGMENTS |
|---|
This work was supported by AstraZeneca Pharmaceuticals (Wilmington, Del.); Aventis Pharmaceuticals (Parsippany, N.J.); Bayer Corporation (West Haven, Conn.); Elan Pharmaceuticals (San Diego, Calif.); Eli Lilly and Company (Indianapolis, Ind.); Merck and Co., Inc. (West Point, Pa.); Pharmacia and Upjohn (Peapack, N.J.), Roche Pharmaceuticals (Nutley, N.J.); and Wyeth-Ayerst Pharmaceuticals (Philadelphia, Pa.)
| |
FOOTNOTES |
|---|
* Corresponding author. Mailing address: Box 77, SUNY Downstate Medical Center, 450 Clarkson Ave., Brooklyn, NY 11203. Phone: (718) 270-2148. Fax: (718) 270-2465. E-mail: dlandman{at}downstate.edu.
| |
REFERENCES |
|---|
|
|
|---|
| 1. | Corso, A., E. P. Severina, V. F. Petruk, Y. R. Mauriz, and A. Tomasz. 1998. Molecular characterization of penicillin-resistant Streptococcus pneumoniae isolates causing respiratory disease in the United States. Microb. Drug Resist. 4:325-337[Medline]. |
| 2. | Davies, T., R. V. Goering, M. Lovgren, J. A. Talbot, M. R. Jacobs, and P. C. Appelbaum. 1999. Molecular epidemiological survey of penicillin-resistant Streptococcus pneumoniae from Asia, Europe, and North America. Diagn. Microbiol. Infect. Dis. 34:7-12[CrossRef][Medline]. |
| 3. | Hall, L. M. C. 1998. Application of molecular typing to the epidemiology of Streptococcus pneumoniae. J. Clin. Pathol. 51:270-274[Abstract]. |
| 4. |
Harakeh, H.,
G. S. Bosley,
J. A. Keihlbauch, and B. S. Fields.
1994.
Heterogeneity of rRNA gene restriction patterns of multiresistant serotype 6B Streptococcus pneumoniae strains.
J. Clin. Microbiol.
32:3046-3048 |
| 5. | Hermans, P. W. M., M. Sluijter, T. Hoogenboezem, H. Heersma, A. van Belkum, and R. de Groot. 1995. Comparative study of five different DNA fingerprint techniques for molecular typing of Streptococcus pneumoniae strains. J. Clin. Microbiol. 33:1606-1612[Abstract]. |
| 6. | Hermans, P. W. M., M. Sluijter, K. Elzenaar, A. van Veen, J. J. M. Schonkeren, F. M. Nooren, W. J. van Leeuwen, A. J. de Neeling, B. van Klingeren, H. A. Verbrugh, and R. de Groot. 1997. Penicillin-resistant Streptococcus pneumoniae in The Netherlands: results of a 1-year molecular epidemiologic survey. J. Infect. Dis. 175:1413-1422[Medline]. |
| 7. |
Kell, C. M.,
J. Z. Jordans,
M. Daniels,
T. J. Coffey,
J. Bates,
J. Paul,
C. Gilks, and B. G. Spratt.
1993.
Molecular epidemiology of penicillin-resistant pneumococci isolated in Nairobi, Kenya.
Infect. Immun.
61:4382-4391 |
| 8. |
McDougal, L. K.,
R. Facklam,
M. Reeves,
S. Hunter,
J. M. Swenson,
B. C. Hill, and F. C. Tenover.
1992.
Analysis of multiply antimicrobial-resistant isolates of Streptococcus pneumoniae from the United States.
Antimicrob. Agents Chemother.
36:2176-2184 |
| 9. | McDougal, L. K., J. K. Rasheed, J. W. Biddle, and F. C. Tenover. 1995. Identification of multiple clones of extended-spectrum cephalosporin-resistant Streptococcus pneumoniae isolates in the United States. Antimicrob. Agents Chemother. 39:2282-2288[Abstract]. |
| 10. | National Committee for Clinical Laboratory Standards. 2001. Performance standards for antimicrobial susceptibility testing. Eleventh informational supplement. Document M100-S11. National Committee for Clinical Laboratory Standards, Wayne, Pa. |
| 11. |
Smith, A. M.,
K. Klugman,
T. J. Coffey, and B. G. Spratt.
1993.
Genetic diversity of penicillin-binding protein 2B and 2X genes from Streptococcus pneumoniae in South Africa.
Antimicrob. Agents Chemother.
37:1938-1944 |
| 12. | Soares, S., K. G. Kristinsson, J. M. Musser, and A. Tomasz. 1993. Evidence for the introduction of a multiresistant clone of serotype 6B Streptococcus pneumoniae from Spain to Iceland in the late 1980s. J. Infect. Dis. 168:158-163[Medline]. |
| 13. |
Song, J.,
J. Yang,
J. H. Jin,
S. W. Kim,
C. K. Kim,
H. Lee,
K. R. Peck,
S. Kim,
N. Y. Lee,
M. R. Jacobs, and P. C. Appelbaum.
2000.
Molecular characterization of multidrug-resistant Streptococcus pneumoniae isolates from Korea.
J. Clin. Microbiol.
38:1641-1644 |
| 14. | Tenover, F. C., R. D. Arbeit, R. V. Goering, P. A. Mickelson, B. E. Murray, D. H. Persing, and B. Swaminathan. 1995. Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: criteria for bacterial strain typing. J. Clin. Microbiol. 33:2233-2239[Medline]. |
| 15. | Versalovic, J., V. Kapur, E. O. Mason, Jr., U. Shah, T. Koeuth, J. R. Lupski, and J. M. Musser. 1993. Penicillin-resistant Streptococcus pneumoniae strains recovered in Houston: identification and molecular characterization of multiple clones. J. Infect. Dis. 167:850-856[Medline]. |
| 16. |
Whitney, C. G.,
M. M. Farley,
J. Hadler,
L. H. Harrison,
C. Lexau,
A. Reingold,
L. Lefkowitz,
P. R. Cieslak,
M. Cetron,
E. R. Zell,
J. H. Jorgensen, and A. Schuchat.
2000.
Increasing prevalence of multidrug-resistant Streptococcus pneumoniae in the United States.
N. Engl. J. Med.
343:1917-1924 |
| 17. |
Wolf, B.,
L. C. Rey,
S. Brisse,
L. B. Moreira,
D. Milatovic,
A. Fleer,
J. J. Roord, and J. Verhoef.
2000.
Molecular epidemiology of penicillin-resistant Streptococcus pneumoniae colonizing children with community-acquired pneumoniae and children attending day-care centers in Fortaleza, Brazil.
J. Antimicrob. Chemother.
46:757-765 |
This article has been cited by other articles:
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Antimicrob. Agents Chemother. | Clin. Microbiol. Rev. |
|---|---|
| Clin. Vaccine Immunol. | ALL ASM JOURNALS |
|---|